NASDAQ:XOMA
XOMA Corporation Stock News
$25.64
-0.450 (-1.72%)
At Close: Apr 24, 2024
XOMA to Present at Upcoming Investor Conferences in March
07:30am, Wednesday, 28'th Feb 2024
EMERYVILLE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following M
I'm Buying Preferred Stocks Hand Over Fist
08:30am, Friday, 15'th Dec 2023
Preferred shares present a desirable trifecta of high yields, lower risk, and significant capital upside. At these bargain prices, preferred stocks have something for value, income, and growth investo
Xoma (XOMA) Moves 7.7% Higher: Will This Strength Last?
02:18pm, Monday, 18'th Sep 2023
Xoma (XOMA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
XOMA to Present at H.C. Wainwright BioConnect Investor Conference
07:30am, Wednesday, 26'th Apr 2023
EMERYVILLE, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the Biotech Royalty Aggregator, announced today Owen Hughes, Executive Chairman, and Brad Sitko, Chief Investmen
XOMA to Present at 43rd Annual Cowen Health Care Conference
07:30am, Tuesday, 28'th Feb 2023
EMERYVILLE, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the Biotech Royalty Aggregator, announced today that Owen Hughes, Executive Chairman, and Brad Sitko, Chief Inves
XOMA to Present at H.C. Wainwright 24th Annual Global Investment Conference
07:30am, Wednesday, 07'th Sep 2022
EMERYVILLE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improvi
Xoma (XOMA) Reports Q2 Loss, Misses Revenue Estimates
12:02pm, Thursday, 04'th Aug 2022
Xoma (XOMA) delivered earnings and revenue surprises of -381.82% and 88.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
XOMA to Present at H.C. Wainwright Global Investment Conference
08:05pm, Tuesday, 17'th May 2022 GlobeNewswire Inc.
EMERYVILLE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improvi
XOMA to Present at H.C. Wainwright Global Investment Conference
04:05pm, Tuesday, 17'th May 2022
EMERYVILLE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improving
XOMA: First Steps Towards Greatness
09:00am, Thursday, 12'th May 2022
While XOMA offers an investment into an important sector of healthcare, drug revenue royalties, the story is just beginning. From first glance, years of losses and flat revenues look poor, but somethi
Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates
12:55pm, Thursday, 05'th May 2022 Zacks Investment Research
Xoma (XOMA) delivered earnings and revenue surprises of 5.88% and 12.73%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates
10:33am, Thursday, 05'th May 2022
Xoma (XOMA) delivered earnings and revenue surprises of 5.88% and 12.73%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Lags Revenue Estimates
12:15pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Kymera Therapeutics, Inc. (KYMR) delivered earnings and revenue surprises of -5.97% and 44.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the sto
XOMA Declares Quarterly Preferred Stock Dividends
11:30am, Monday, 21'st Mar 2022 GlobeNewswire Inc.
EMERYVILLE, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash divi
XOMA to Present at Oppenheimer’s 32nd Annual Healthcare Conference
12:30pm, Thursday, 10'th Mar 2022 GlobeNewswire
EMERYVILLE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improving human health, announced today its Chairman and Chief Executive Officer, Jim Neal, will present at Oppenheimer’s 32 nd Annual Healthcare Conference (virtual) on Thursday, March 17, 2022, at 12:40 PM ET.
